US Stocks
/
Tvardi Therapeutics, Inc. Share Price

Tvardi Therapeutics, Inc. Share Price

NASDAQ: TVRD | Micro Cap
$1.03
-$0.04 (-3.27%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Tvardi Therapeutics, Inc. Stock Performance

Open
$1.05
Prev. Close
$1.07
Circuit Range
N/A
Day Range
$1.03 - $1.06
Year Range
$0.94 - $43.27
Volume
1,864
Average Traded
$1.04

Tvardi Therapeutics, Inc. Share Price Today

As of 11 October 2026, Tvardi Therapeutics, Inc.'s share price is $1.03. The stock opened at $1.05, compared to its previous close of $1.07. During today's trading session, Tvardi Therapeutics, Inc.'s share price traded between $1.03 and $1.06, with an average price of $1.04. Over the past 52 weeks, the stock has recorded a high of $43.27 and a low of $0.94. In terms of performance, Tvardi Therapeutics, Inc.'s share price has declined by 66.93% over the last six months and is down 77.81% on a year-on-year basis.

Tvardi Therapeutics, Inc. Share Price Chart

$1.03$1.06
L
Show Current Price
H

Tvardi Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$7.68M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.95
Revenue (TTM)
$0.00
Return On Equity (TTM)
-310.94%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-16.82%

Tvardi Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$5.53-$7.28-$6.80-$6.46
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-31.65%6.59%5.00%

Tvardi Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2025
Revenue$0.00
Net Profit-$18.21
Net Profit MarginN/A
Income ChangeN/A

About Tvardi Therapeutics, Inc.

Tvardi Therapeutics Inca clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting Signal Transducer and Activator of Transcription 3 (STAT3) to treat inflammatory and proliferative diseases with unmet need. Its pipeline includes two oral, small molecule STAT3 inhibitors: TTI-101 and TTI-109. TTI-101 is its first-generation direct STAT3 inhibitor, currently in Phase 1b/2 clinical development in hepatocellular carcinoma (HCC). TTI-109 is a phosphate prodrug of TTI-101 that is mechanistically identical to its parent molecule but is designed to enhance its ability to target STAT3.

Tvardi Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$1.22
$1.04
-16.13%
Sep 2026
$1.81
$1.24
-32.24%
Aug 2026
$2.06
$1.83
-13.27%
Jul 2026
$1.86
$2.11
+9.61%
Jun 2026
$3.33
$1.93
-43.22%
May 2026
$3.13
$3.39
+8.31%
Apr 2026
$3.11
$3.13
-1.57%
Mar 2026
$4.11
$3.18
-20.10%
Feb 2026
$3.93
$3.98
+0.76%
Jan 2026
$4.26
$3.95
-8.35%
Dec 2025
$4.08
$4.31
+4.48%
Nov 2025
$4.63
$4.13
-11.58%

TVRD Share Price FAQs

What is Tvardi Therapeutics, Inc. share price today?

chevron-up
Tvardi Therapeutics, Inc. share price today is $1.03 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Tvardi Therapeutics, Inc. stock?

chevron-up
The 52 week high of Tvardi Therapeutics, Inc. stock is $43.27, while the 52 week low is $0.94 as of 10 Oct '26.

What is TVRD's market capitalisation today?

chevron-up
TVRD market capitalisation is $7.68M as of October 11, 2026, at 4:01 pm IST.

What is TVRD's net income for the last quarter?

chevron-up
TVRD's net income for the last quarter is -6.46B USD.

What is the 5 year returns of TVRD?

chevron-up
The 5 year returns of TVRD is -99.83% as on 10 Oct '26.

What is the high & low stock price of TVRD today?

chevron-up
TVRD stock price hit a high of $1.06 and low of $1.03 as of 10 Oct '26.

Can I buy TVRD shares in India?

chevron-up
Yes. You can buy TVRD in India by opening an international trading account.